Pseudomonas aeruginosa Population Structure Revisited

被引:188
作者
Pirnay, Jean-Paul
Bilocq, Florence
Pot, Bruno
Cornelis, Pierre
Zizi, Martin
Van Eldere, Johan
Deschaght, Pieter
Vaneechoutte, Mario
Jennes, Serge
Pitt, Tyrone
De Vos, Daniel
机构
[1] Laboratory for Molecular and Cellular Technology, Burn Centre, Queen Astrid Military Hospital, Brussel
[2] Applied Maths, Sint-Martens-Latem
[3] Laboratory of Microbial Interactions, Department of Molecular and Cellular Interactions, Vrije Universiteit Brussel, Brussel
[4] Department of Physiology, Vrije Universiteit Brussel, Brussel
[5] Rega Institute and Laboratory of Microbiology, Gasthuisberg University Hospital, Catholic University of Leuven, Leuven
[6] Laboratory for Bacteriology Research, Department of Chemistry, Microbiology and Immunology, Ghent University, Ghent
[7] Laboratory of Healthcare Associated Infection, Specialist and Reference Microbiology Division, Health Protection Agency, London
关键词
CYSTIC-FIBROSIS PATIENTS; OUTER-MEMBRANE LIPOPROTEIN; FRAGMENT-LENGTH-POLYMORPHISM; I FERRIPYOVERDINE RECEPTOR; FIELD GEL-ELECTROPHORESIS; METALLO-BETA-LACTAMASE; POOR CLINICAL-OUTCOMES; INTENSIVE-CARE-UNIT; MOLECULAR EPIDEMIOLOGY; EXOENZYME-S;
D O I
10.1371/journal.pone.0007740
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
At present there are strong indications that Pseudomonas aeruginosa exhibits an epidemic population structure; clinical isolates are indistinguishable from environmental isolates, and they do not exhibit a specific (disease) habitat selection. However, some important issues, such as the worldwide emergence of highly transmissible P. aeruginosa clones among cystic fibrosis (CF) patients and the spread and persistence of multidrug resistant (MDR) strains in hospital wards with high antibiotic pressure, remain contentious. To further investigate the population structure of P. aeruginosa, eight parameters were analyzed and combined for 328 unrelated isolates, collected over the last 125 years from 69 localities in 30 countries on five continents, from diverse clinical (human and animal) and environmental habitats. The analysed parameters were: i) O serotype, ii) Fluorescent Amplified-Fragment Length Polymorphism (FALFP) pattern, nucleotide sequences of outer membrane protein genes, iii) oprI, iv) oprL, v) oprD, vi) pyoverdine receptor gene profile (fpvA type and fpvB prevalence), and prevalence of vii) exoenzyme genes exoS and exoU and viii) group I pilin glycosyltransferase gene tfpO. These traits were combined and analysed using biological data analysis software and visualized in the form of a minimum spanning tree (MST). We revealed a network of relationships between all analyzed parameters and non-congruence between experiments. At the same time we observed several conserved clones, characterized by an almost identical data set. These observations confirm the nonclonal epidemic population structure of P. aeruginosa, a superficially clonal structure with frequent recombinations, in which occasionally highly successful epidemic clones arise. One of these clones is the renown and widespread MDR serotype O12 clone. On the other hand, we found no evidence for a widespread CF transmissible clone. All but one of the 43 analysed CF strains belonged to a ubiquitous P. aeruginosa "core lineage" and typically exhibited the exoS(+)/exoU(-) genotype and group B oprL and oprD alleles. This is to our knowledge the first report of an MST analysis conducted on a polyphasic data set.
引用
收藏
页数:20
相关论文
共 119 条
[1]   MARKED INCREASE OF PSEUDOMONAS-AERUGINOSA SEROTYPE-012 IN BELGIUM SINCE 1982 [J].
ALLEMEERSCH, D ;
BEUMER, J ;
DEVLEESCHOUWER, M ;
DEMAEYER, S ;
DONY, J ;
GODARD, C ;
OSTERRIETH, P ;
PITHSY, A ;
VANDERAUWERA, P ;
VANPOPPEL, H ;
VERSCHRAEGEN, G ;
WEGGE, M ;
WILDEMAUWE, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (02) :265-269
[2]   Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin [J].
Alonso, A ;
Rojo, F ;
Martínez, JL .
ENVIRONMENTAL MICROBIOLOGY, 1999, 1 (05) :421-430
[3]  
Amsterdam D., 1991, ANTIBIOTICS LAB MED, P72
[4]   Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients [J].
Anthony, M ;
Rose, B ;
Pegler, MB ;
Elkins, M ;
Service, H ;
Thamotharampillai, K ;
Watson, J ;
Robinson, M ;
Bye, P ;
Merlino, J ;
Harbour, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (08) :2772-2778
[5]  
AOKI K, 1926, ZBL BAKTER 1, V98, P186
[6]   Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics [J].
Armstrong, D ;
Bell, S ;
Robinson, M ;
Bye, P ;
Rose, B ;
Harbour, C ;
Lee, C ;
Service, H ;
Nissen, M ;
Syrmis, M ;
Wainwright, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (05) :2266-2267
[7]   Uptake of pyocin S3 occurs through the outer membrane ferripyoverdine type II receptor of Pseudomonas aeruginosa [J].
Baysse, C ;
Meyer, JM ;
Plesiat, P ;
Geoffroy, V ;
Michel-Briand, Y ;
Cornelis, P .
JOURNAL OF BACTERIOLOGY, 1999, 181 (12) :3849-3851
[8]   Comparitive distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards [J].
Bert, F ;
LambertZechovsky, N .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (04) :809-813
[9]   Molecular epidemiology provides evidence of genotypic heterogeneity of multidrug-resistant Pseudomonas aeruginosa serotype O:12 outbreak isolates from a pediatric hospital [J].
Bingen, E ;
Bonacorsi, S ;
Rohrlich, P ;
Duval, M ;
Lhopital, S ;
Brahimi, N ;
Vilmer, E ;
Goering, RV .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (12) :3226-3229
[10]  
BODILIS J, 2009, ENV MICROBIOL 0421